Will the Theranos scandal put a damper on medical tech investing?

Jun 19, 2018
It's become a cautionary tale for biotech investors. Are they heeding it?
Elizabeth Holmes speaks during the closing session of the Clinton Global Initiative 2015 in New York City.
JP Yim/Getty Images

Holmes surrenders Theranos, pays $500K after "massive fraud"

Mar 14, 2018
The settlement comes two years after the SEC began looking into claims at Theranos that it had developed potentially revolutionary blood-testing technology.
Elizabeth Holmes (L), founder and CEO of Theranos being interviewed by Matthew Herper, a senior editor for Forbes Media, at Forbes Under 30 Summit on Oct. 5, 2015.
Lisa Lake/Getty Images

Forbes drops Theranos CEO's net worth to zero

Jun 1, 2016
From $4.5 billion to nothing.
Elizabeth Holmes speaks on stage during the closing session of the Clinton Global Initiative in 2015.
JP Yim/Getty Images

Theranos voids two years of botched blood-test results

May 19, 2016
The Wall Street Journal reports tens of thousands of corrections were issued.
NBC's Maria Shriver, left, interviews Theranos Founder and CEO Elizabeth Holmes at the Vanity Fair New Establishment Summit in San Francisco in 2015.
Mike Windle/Getty Images